Cargando…

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis

BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Dae Hoe, Kim, Moon Young, Seo, Yeon Seok, Kim, Sang Gyune, Lee, Han Ah, Kim, Tae Hyung, Jung, Young Kul, Kandemir, Altay, Kim, Ji Hoon, An, Hyunggin, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo, Um, Soon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166111/
https://www.ncbi.nlm.nih.gov/pubmed/29706058
http://dx.doi.org/10.3350/cmh.2017.0077
_version_ 1783359974193233920
author Gu, Dae Hoe
Kim, Moon Young
Seo, Yeon Seok
Kim, Sang Gyune
Lee, Han Ah
Kim, Tae Hyung
Jung, Young Kul
Kandemir, Altay
Kim, Ji Hoon
An, Hyunggin
Yim, Hyung Joon
Yeon, Jong Eun
Byun, Kwan Soo
Um, Soon Ho
author_facet Gu, Dae Hoe
Kim, Moon Young
Seo, Yeon Seok
Kim, Sang Gyune
Lee, Han Ah
Kim, Tae Hyung
Jung, Young Kul
Kandemir, Altay
Kim, Ji Hoon
An, Hyunggin
Yim, Hyung Joon
Yeon, Jong Eun
Byun, Kwan Soo
Um, Soon Ho
author_sort Gu, Dae Hoe
collection PubMed
description BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients. METHODS: All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm(2) /m(2) in men and ≤38.5 cm(2) /m(2) in women) for SMI-sarcopenia and (2) cutoff of PMTH (<16.8 mm/m) for PMTH-sarcopenia. RESULTS: Six hundred fifty-three patients were included. The average age was 53.6 ± 10.2 years, and 499 patients (76.4%) were men. PMTH correlated well with SMI in both men and women (P<0.001). Two hundred forty-one (36.9%) patients met the criteria for SMI-sarcopenia. The best PMTH cutoff values for predicting SMI-sarcopenia were 17.3 mm/m in men and 10.4 mm/m in women, and these were defined as sex-specific cutoffs of PMTH (SsPMTH). The previously published cutoff of PMTH was defined as sex-nonspecific cutoff of PMTH (SnPMTH). Two hundred thirty (35.2%) patients were diagnosed with SsPMTH-sarcopenia, and 280 (44.4%) patients were diagnosed with SnPMTH-sarcopenia. On a multivariate Cox regression analysis, SsPMTH-sarcopenia (hazard ratio [HR], 1.944; 95% confidence interval [CI], 1.144–3.304; P=0.014) was significantly associated with mortality, while SnPMTH-sarcopenia was not (HR, 1.446; 95% CI, 0.861–2.431; P=0.164). CONCLUSIONS: PMTH was well correlated with SMI in cirrhotic patients. SsPMTH-sarcopenia was an independent predictor of mortality in these patients and more accurately predicted mortality compared to SnPMTH-sarcopenia.
format Online
Article
Text
id pubmed-6166111
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-61661112018-10-04 Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis Gu, Dae Hoe Kim, Moon Young Seo, Yeon Seok Kim, Sang Gyune Lee, Han Ah Kim, Tae Hyung Jung, Young Kul Kandemir, Altay Kim, Ji Hoon An, Hyunggin Yim, Hyung Joon Yeon, Jong Eun Byun, Kwan Soo Um, Soon Ho Clin Mol Hepatol Original Article BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients. METHODS: All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm(2) /m(2) in men and ≤38.5 cm(2) /m(2) in women) for SMI-sarcopenia and (2) cutoff of PMTH (<16.8 mm/m) for PMTH-sarcopenia. RESULTS: Six hundred fifty-three patients were included. The average age was 53.6 ± 10.2 years, and 499 patients (76.4%) were men. PMTH correlated well with SMI in both men and women (P<0.001). Two hundred forty-one (36.9%) patients met the criteria for SMI-sarcopenia. The best PMTH cutoff values for predicting SMI-sarcopenia were 17.3 mm/m in men and 10.4 mm/m in women, and these were defined as sex-specific cutoffs of PMTH (SsPMTH). The previously published cutoff of PMTH was defined as sex-nonspecific cutoff of PMTH (SnPMTH). Two hundred thirty (35.2%) patients were diagnosed with SsPMTH-sarcopenia, and 280 (44.4%) patients were diagnosed with SnPMTH-sarcopenia. On a multivariate Cox regression analysis, SsPMTH-sarcopenia (hazard ratio [HR], 1.944; 95% confidence interval [CI], 1.144–3.304; P=0.014) was significantly associated with mortality, while SnPMTH-sarcopenia was not (HR, 1.446; 95% CI, 0.861–2.431; P=0.164). CONCLUSIONS: PMTH was well correlated with SMI in cirrhotic patients. SsPMTH-sarcopenia was an independent predictor of mortality in these patients and more accurately predicted mortality compared to SnPMTH-sarcopenia. The Korean Association for the Study of the Liver 2018-09 2018-04-30 /pmc/articles/PMC6166111/ /pubmed/29706058 http://dx.doi.org/10.3350/cmh.2017.0077 Text en Copyright © 2018 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Gu, Dae Hoe
Kim, Moon Young
Seo, Yeon Seok
Kim, Sang Gyune
Lee, Han Ah
Kim, Tae Hyung
Jung, Young Kul
Kandemir, Altay
Kim, Ji Hoon
An, Hyunggin
Yim, Hyung Joon
Yeon, Jong Eun
Byun, Kwan Soo
Um, Soon Ho
Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
title Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
title_full Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
title_fullStr Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
title_full_unstemmed Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
title_short Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
title_sort clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166111/
https://www.ncbi.nlm.nih.gov/pubmed/29706058
http://dx.doi.org/10.3350/cmh.2017.0077
work_keys_str_mv AT gudaehoe clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT kimmoonyoung clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT seoyeonseok clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT kimsanggyune clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT leehanah clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT kimtaehyung clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT jungyoungkul clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT kandemiraltay clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT kimjihoon clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT anhyunggin clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT yimhyungjoon clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT yeonjongeun clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT byunkwansoo clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis
AT umsoonho clinicalusefulnessofpsoasmusclethicknessforthediagnosisofsarcopeniainpatientswithlivercirrhosis